Roche Holding AG (ROG.VX: Quote, Profile, Research) still opposes major mergers as destructive distractions but would actively consider more deals such as its acquisition of a majority stake in U.S. biotech arm Genentech Inc (DNA.N: Quote, Profile, Research) , its chairman said.
